ALVOTECH SA(NASDAQ:ALVO) stock News

ALVO Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill

Alvotech SA (NASDAQ:ALVO) Surpasses Q2 2025 Estimates with Strong Revenue and EPS Growth

2 days ago - By: Chartmill - Mentions: FOSL RRGB COHR CDXS ...

Curious about the stocks that are showing activity after the closing bell on Wednesday?

a day ago - By: Zacks Investment Research - Mentions: CRMD ZYME KOD

Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus

2 days ago - By: Zacks Investment Research - Mentions: PAHC

Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates

2 days ago - By: Benzinga - Mentions: CDXS VSTM PULM SNOA ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 days ago - By: Alvotech - Mentions: SDB

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

2 days ago - By: Alvotech

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

2 days ago - By: Alvotech

Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjustu áfanga í rekstri félagsins

2 days ago - By: Zacks Investment Research

Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet

3 days ago - By: Zacks Investment Research - Mentions: ADCT

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

3 days ago - By: Benzinga

Alvotech's Earnings: A Preview

3 days ago - By: Zacks Investment Research - Mentions: CRMD ZYME IMVT

Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus

3 days ago - By: Zacks Investment Research - Mentions: NBIX CRMD XENE

Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus

9 days ago - By: Zacks Investment Research - Mentions: TVTX

Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates

10 days ago - By: Alvotech - Mentions: SDB

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

10 days ago - By: Alvotech

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

10 days ago - By: Alvotech

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á hádegi

10 days ago - By: Alvotech

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten för första halvåret 2025

23 days ago - By: Yahoo Finance - Mentions: RDY

Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement

a month ago - By: Yahoo Finance

Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group

a month ago - By: Alvotech - Mentions: SDB

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

a month ago - By: Alvotech

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

a month ago - By: Alvotech

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs

a month ago - By: Alvotech - Mentions: SDB

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

a month ago - By: Alvotech

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

a month ago - By: Alvotech

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland

a month ago - By: Alvotech

Alvotech kaupir alla starfsemi Ivers-Lee Grou

a month ago - By: Alvotech

Alvotech förvärvar Ivers-Lee Group i Schweiz och utökar kapacitet inom montering och förpackning

a month ago - By: Alvotech

Alvotech erweitert seine Kapazitäten in den Bereichen Montage und Verpackung mit der Akquisition von Ivers-Lee in der Schweiz

a month ago - By: Yahoo Finance - Mentions: VZ NEGG

Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma

a month ago - By: Alvotech

Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers

2 months ago - By: Alvotech

Granting of Stock Options and Vesting of Restricted Share Units

2 months ago - By: Alvotech

Úthlutun nýrra kauprétta og afhending áunninna hlutabréfaréttinda

2 months ago - By: Alvotech - Mentions: SDB

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

2 months ago - By: Alvotech

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

2 months ago - By: Alvotech

Advanz Pharma semur við Alvotech um markaðssetningu í Evrópu á hliðstæðu við líftæknilyfið Cimzia

2 months ago - By: Alvotech

Alvotech and Advanz Pharma ingår europeiskt leverans- och kommersialiseringsavtal för biosimilarkandidat till Cimzia® (certolizumab pegol)

2 months ago - By: Alvotech

ALVOTECH SA (ALVO) Stock News

ALVO Latest News, Press Relases and Analysis

Alvotech SA (NASDAQ:ALVO) Surpasses Q2 2025 Estimates with Strong Revenue and EPS Growth

Curious about the stocks that are showing activity after the closing bell on Wednesday?

Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus

Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates

12 Health Care Stocks Moving In Wednesday's After-Market Session

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjustu áfanga í rekstri félagsins

Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

Alvotech's Earnings: A Preview

Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus

Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus

Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á hádegi

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten för första halvåret 2025

Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement

Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland

Alvotech kaupir alla starfsemi Ivers-Lee Grou

Alvotech förvärvar Ivers-Lee Group i Schweiz och utökar kapacitet inom montering och förpackning

Alvotech erweitert seine Kapazitäten in den Bereichen Montage und Verpackung mit der Akquisition von Ivers-Lee in der Schweiz

Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma

Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers

Granting of Stock Options and Vesting of Restricted Share Units

Úthlutun nýrra kauprétta og afhending áunninna hlutabréfaréttinda

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

Advanz Pharma semur við Alvotech um markaðssetningu í Evrópu á hliðstæðu við líftæknilyfið Cimzia

Alvotech and Advanz Pharma ingår europeiskt leverans- och kommersialiseringsavtal för biosimilarkandidat till Cimzia® (certolizumab pegol)

Alvotechs långivare sänker räntan på senior säkerställd lånefacilitet